| LP267976-1 | I felt like crying in past 7 days | COMPONENT | 1 |
| LP267977-9 | I had mood swings in past 7 days | COMPONENT | 1 |
| LP267980-3 | Does your health now limit you in traveling out of town for an overnight stay | COMPONENT | 1 |
| LP267981-1 | Does your health now limit you in pursuing your hobbies or other leisure activities | COMPONENT | 1 |
| LP267982-9 | Does your health now limit you in doing recreational activities which require little exertion (e.g., card playing, knitting, etc.) | COMPONENT | 1 |
| LP267983-7 | Does your health now limit you in doing housework or jobs around the house | COMPONENT | 1 |
| LP267984-5 | Are you able to run on uneven ground | COMPONENT | 1 |
| LP267985-2 | Are you able to do two hours of physical labor | COMPONENT | 1 |
| LP267986-0 | IgA+IgM | SUFFIX | |
| LP267987-8 | Mycobacterium tuberculosis gyrA gene fluoroquinolone resistance mutation | COMPONENT | 1 |
| LP267991-0 | Collection setting | COMPONENT | 1 |
| LP267992-8 | Treatment history of specimen | COMPONENT | 1 |
| LP267993-6 | Does your health now limit you in exercising regularly | COMPONENT | 1 |
| LP267994-4 | Are you able to climb several flights of stairs | COMPONENT | 1 |
| LP268038-9 | Guidance for drainage of pseudocyst | COMPONENT | |
| LP268041-3 | Guidance greater than 2 levels for injection | COMPONENT | 1 |
| LP268042-1 | Guidance 2 levels for injection | COMPONENT | 2 |
| LP268043-9 | Guidance 1 level for injection | COMPONENT | 3 |
| LP268045-4 | Event activation or deactivation | COMPONENT | 1 |
| LP268046-2 | Event identifier | COMPONENT | 1 |
| LP268047-0 | Event description | COMPONENT | 1 |
| LP268048-8 | Condition triggering EOC response termination | COMPONENT | 1 |
| LP268049-6 | Condition triggering EOC response activation | COMPONENT | 1 |
| LP268050-4 | Incident commander qualification | COMPONENT | 1 |
| LP268051-2 | Incident commander name | COMPONENT | 1 |
| LP268052-0 | Incident commander phone number | COMPONENT | 1 |
| LP268053-8 | Incident commander email address | COMPONENT | 1 |
| LP268057-9 | Emergency response capabilities | COMPONENT | 1 |
| LP268058-7 | Organization contact information panel | COMPONENT | 1 |
| LP268059-5 | Primary contact information panel | COMPONENT | 1 |
| LP268060-3 | Emergency management plan name | COMPONENT | 1 |
| LP268081-9 | Skin type | COMPONENT | 1 |
| LP268082-7 | Globotriaosylsphingosine | COMPONENT | 3 |
| LP268083-5 | Perirenal space - left | SYSTEM | 1 |
| LP268084-3 | Perirenal space - right | SYSTEM | 1 |
| LP268086-8 | Guidance for transrectal drainage of abscess | COMPONENT | 1 |
| LP268087-6 | Midfoot - right and Forefoot - right | SYSTEM | 1 |
| LP268089-2 | Midfoot - left and Forefoot - left | SYSTEM | 1 |
| LP268090-0 | Pleura - right | SYSTEM | 1 |
| LP268091-8 | Pleura - left | SYSTEM | 1 |
| LP268093-4 | Bacterial whole genome | COMPONENT | 1 |
| LP268094-2 | BRAF gene p.Val600Lys | COMPONENT | 1 |
| LP268095-9 | Eculizumab | COMPONENT | 1 |
| LP268097-5 | Natural killer cell cytotoxicity.IL-stimulated 15:1 effector to target cell ratio | COMPONENT | |
| LP268098-3 | Natural killer cell cytotoxicity.IL-stimulated 7.5:1 effector to target cell ratio | COMPONENT | |
| LP268099-1 | Natural killer cell cytotoxicity.IL-stimulated 3.75:1 effector to target cell ratio | COMPONENT | |
| LP268100-7 | Natural killer cell cytotoxicity.IL-stimulated 1.88:1 effector to target cell ratio | COMPONENT | |
| LP268101-5 | Natural killer cell cytotoxicity.IL-stimulated 0.9:1 effector to target cell ratio | COMPONENT | |
| LP268102-3 | Insulin was taken in last 8H | COMPONENT | 1 |
| LP268103-1 | Coagulation factor VII activity and inhibitor panel | COMPONENT | 1 |